Skip to main content
. 2020 Apr 9;4(7):1440–1447. doi: 10.1182/bloodadvances.2019001305

Table 6.

CTCAE, mCRES, and ASTCT NT grades for patients with or without CRS per Penn Scale

Patients with CRS (N = 64), n (%) Patients without CRS (N = 47), n (%)
CTCAE expert regrade mCRES ASTCT CTCAE expert regrade mCRES ASTCT
Grade 1/2 19 (29.7) 5 (7.8) 5 (7.8) 15 (31.9) 0 (0) 0 (0)
Grade 3 7 (10.9) 4 (6.3) 6 (9.4) 4 (8.5) 2 (4.3) 2 (4.3)
Grade 4 4 (6.3) 6 (9.4) 4 (6.3) 1 (2.1) 2 (4.3) 2 (4.3)
Grade 5 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Total 30 (46.9) 15 (23.4) 15 (23.4) 20 (42.6) 4 (8.5) 4 (8.5)